CDK4 and cancer: CDK4/6i‐induced senescent cancer cells clearly showed less prominent expression of SASP and ligands associated with inflammation and angiogenesis, while comparable or even higher expression of SASP and ligands associated with anti‐tumor immunity compared to DNA‐damaging agent‐induced senescent cancer cells.